Usefulness of Plasma Amyloid as a Prescreener for the Earliest Alzheimer Pathological Changes Depends on the Study Population

Ann Neurol. 2020 Jan;87(1):154-155. doi: 10.1002/ana.25634. Epub 2019 Nov 13.

Authors

Samantha Prins¹, Ahnjili Zhuparris¹, Geert Jan Groeneveld

Affiliation

¹ Centre for Human Drug Research, Leiden, the Netherlands.

PMID: 31675127
DOI: 10.1002/ana.25634

No abstract available

Publication types

Letter
Comment

MeSH terms

Alzheimer Disease*
Amyloid
Amyloid beta-Peptides
Amyloidosis*
Humans
Plasma

Substances

Amyloid
Amyloid beta-Peptides